Albert Fosmoe is CEO of AuxThera, and has over twenty years of extensive “C” level and “hands on” product development, manufacturing, quality, and regulatory experience in FDA and EMEA regulated food, medical device, drug, and biological companies for both human and animal products.
Mr. Fosmoe started his career with various positions of increasing product development, manufacturing, quality and regulatory responsibility in his 8 years at US Biomaterials, an implantable medical device company. At OxThera (a.k.a. Ixion Biotechnology), Mr. Fosmoe had escalating management responsibilities including senior level positions as both Chief Operations Officer where he was responsible for product development and subsequent manufacturing of OxThera’s biological therapeutic products, and Chief Regulatory Officer where he was responsible for all US (FDA) and EU(EMA) regulatory operations and submissions. More recently, Albert worked with Banyan Biomarkers developing products for tramautic brain injury, and Oragenics as Sr. VP Product Development and Operations, developing a new class of antibiotics.
Bachelors of Science in Chemistry, University of Florida with graduate studies in Material Science and Engineering under Professor Larry Hench